Prolonged versus single dose in penicillin oral challenge testing: protocols for a pilot and definitive randomised controlled trial (PROSPECTOR studies)Irvin Ng, Fiona James, Ana Copaescu, Sara Vogrin, Elise Mitri, Morgan Rose, Richard Sullivan, Michael Lane, Amy Legg, Jack Godsell, Suran Fernando, Lene Heise Garvey, Vito Sabato, Philip Li, Jonathan Grant PeterSee the full list of authors
22 February 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, Eleanor Barnes, Craig Bodman, Ernest Choy, Paola Cicconi, Vivien Dagley, Katie Ewer, Sian Griffin, Debbie Harris, Adrian Hill, Kerenza Hood, Steven Knapper, Shirley PringleSee the full list of authors
20 January 2025
Incidence and prevalence of antiphospholipid syndrome (APS) in the USA (2016–2019): a retrospective database studyMeheni Khellaf, Paul Meisner, Maria Sarno, Piotr Zaremba, Adam Jedrzejczyk, Anna Scowcroft
11 December 2024
Anifrolumab Study for Treatment Effectiveness in the Real World (ASTER) among patients with systemic lupus erythematosus: protocol for an international observational effectiveness studyMarta Mosca, Cathy Emmas, Cassandra Nekeman-Nan, Heide Stirnadel-Farrant, Samuel Chen, Lucy Carty, Miina Waratani, Caroline Seo, Stephanie Chen, Alessandro Sorrentino
21 November 2024
Protocol for a clinically annotated biorepository of samples from Australian immune-compromised patients to investigate the host–microbiome interactionOlivia C Smibert, Jason A Trubiano, Jason C Kwong, Kate A Markey, Monica A Slavin
12 September 2024
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVasDominic Paul McGovern, Mark E McClure, Matthew Coates, Simon Bond, Marcos Martinez Del Pero, Kim Mynard, Jacinta Lee, Rona M Smith, David R Jayne, Menna Ruth Clatworthy, Rachel B Jones,
17 July 2024
Background incidence rates of health outcomes of interest for COVID-19 vaccine safety monitoring in a US population: a claims database analysisSonja Banga, Alena Khromava, Laurence Serradell, Anne-Laure Chabanon, Chunshen Pan, Irisdaly Estevez, Samantha Schilsky, Hannah Kreisberg
11 July 2024
Deep learning model to predict lupus nephritis renal flare based on dynamic multivariable time-series dataSiwan Huang, Yinghua Chen, Yanan Song, Kaiyuan Wu, Tiange Chen, Yuan Zhang, Wenxiao Jia, Hai-Tao Zhang, Dan-Dan Liang, Jing Yang, Cai-Hong Zeng, Xiang Li, Zhi-Hong Liu
14 March 2024
Enteric-coated Mycophenolate Sodium therApy versus cyclophosphamide for induction of Remission in Microscopic PolyAngiitis (EMSAR-MPA trial): study protocol for a randomised controlled trialSijia Li, Shulei Yao, Xuan Tie, Xiaojing Shi, Rongrong Feng, Xiaole Su, Lihua Wang
11 March 2024
Association between asymptomatic hyperuricemia and risk of arthritis, findings from a US National Survey 2007–2018Zhenguo Liang, Dongze WU, Hua Zhang, Jieruo Gu
12 February 2024
